Therapeutic Asset Ratings
4,361 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Olaparib
Ovarian Clear Cell Adenocarcinoma
National Cancer Institute (NCI)
P3
BB
(70)
PEGASPARGASE
B-Cell Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)
P3
BB
(70)
PREDNISONE TABLETS
High Grade B-Cell Lymphoma
National Cancer Institute (NCI)
P3
BB
(70)
5-azacytidine
Recurrent Non-Hodgkin Lymphoma
National Cancer Institute (NCI)
P2
BB
(70)
azd6244
Stage IV Pancreatic Cancer
National Cancer Institute (NCI)
P2
BB
(70)
cc-5013
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
National Cancer Institute (NCI)
P2
BB
(70)
Cyclophosphamide
Head And Neck Carcinoma
National Cancer Institute (NCI)
P2
BB
(70)
Cyclophosphamide
Primary Effusion Lymphoma
National Cancer Institute (NCI)
P2
BB
(70)
Durvalumab
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)
P2
BB
(70)
Fludarabine
Anaplastic Large Cell Lymphoma
National Cancer Institute (NCI)
P2
BB
(70)
Fludarabine
Angioimmunoblastic T-Cell Lymphoma
National Cancer Institute (NCI)
P2
BB
(70)
Ibrutinib
Refractory Diffuse Large B-Cell Lymphoma
National Cancer Institute (NCI)
P2
BB
(70)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Primary Effusion Lymphoma
National Cancer Institute (NCI)
P2
BB
(70)
Inno-206
Primary Effusion Lymphoma
National Cancer Institute (NCI)
P2
BB
(70)
Irinotecan
Adult Acute Megakaryoblastic Leukemia (M7)
National Cancer Institute (NCI)
P2
BB
(70)
Irinotecan
Adult Erythroleukemia (M6a)
National Cancer Institute (NCI)
P2
BB
(70)
PREDNISONE TABLETS
Primary Effusion Lymphoma
National Cancer Institute (NCI)
P2
BB
(70)
(+)-VINCRISTINE
Adult Erythroleukemia (M6a)
National Cancer Institute (NCI)
P2
BB
(70)
VINCRISTINE SULFATE
High Grade B-Cell Lymphoma
National Cancer Institute (NCI)
P2/3
BB
(70)
Busulphan
Leukemia
National Cancer Institute (NCI)
P4
BB
(69)
Eloxatin
Non-Hodgkin Lymphoma
National Cancer Institute (NCI)
P4
BB
(69)
Fludarabine
Lymphoma
National Cancer Institute (NCI)
P4
BB
(69)
gsk1120212
Anaplastic Ganglioglioma
National Cancer Institute (NCI)
P4
BB
(69)
gsk1120212
Anaplastic Pleomorphic Xanthoastrocytoma
National Cancer Institute (NCI)
P4
BB
(69)
gsk1120212
Glioma, High Grade
National Cancer Institute (NCI)
P4
BB
(69)
Showing 126 to 150 of 4,361 assets
Previous
Page 6 of 175
Next